(1S,2S)-2-PIPERAZIN-1-YL-CYCLOHEXANOL
|
- $495 - $787
- Product name: (1S,2S)-2-PIPERAZIN-1-YL-CYCLOHEXANOL
- CAS: 936940-36-2
- MF: C10H20N2O
- MW: 184.28
- EINECS:
- MDL Number:MFCD08445801
- Synonyms:(1S,2S)-2-PIPERAZIN-1-YL-CYCLOHEXANOL;rel-(1R,2R)-2-(1-Piperazinyl)cyclohexanol;Cyclohexanol, 2-(1-piperazinyl)-, (1R,2R)-rel-
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 1g
- 5g
- ManufacturerAK Scientific
- Product number3674AF
- Product description(1S,2S)-2-Piperazin-1-yl-cyclohexanol
- Packaging1g
- Price$718
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCCH0000748
- Product description(1S,2S)-2-PIPERAZIN-1-YLCYCLOHEXANOL 95.00%
- Packaging1G
- Price$672
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11009351
- Product description(1S,2S)-2-(Piperazin-1-yl)cyclohexanol 97%
- Packaging5g
- Price$787
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number021104
- Product description(1S,2S)-2-Piperazin-1-yl-cyclohexanol
- Packaging1g
- Price$495
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 3674AF | (1S,2S)-2-Piperazin-1-yl-cyclohexanol | 1g | $718 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CCH0000748 | (1S,2S)-2-PIPERAZIN-1-YLCYCLOHEXANOL 95.00% | 1G | $672 | 2021-12-16 | Buy |
| Crysdot | CD11009351 | (1S,2S)-2-(Piperazin-1-yl)cyclohexanol 97% | 5g | $787 | 2021-12-16 | Buy |
| Matrix Scientific | 021104 | (1S,2S)-2-Piperazin-1-yl-cyclohexanol | 1g | $495 | 2021-12-16 | Buy |
Properties
Boiling point :309.1±37.0 °C(Predicted)
Density :1.079±0.06 g/cm3(Predicted)
pka :15.12±0.40(Predicted)
Density :1.079±0.06 g/cm3(Predicted)
pka :15.12±0.40(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|